Hemophilia A is a blood clotting disorder caused by a lack of factor VIII - one of the body's clotting factors. Therefore, these patients need to be replaced with factor VIII from outside with the drug product Koate Vial. So what is Koate Vial?

Monoclate-P is used before surgery to control and stop bleeding episodes in people with low factor VIII levels (hemophilia A), who are at risk of bleeding for longer after trauma, surgery, and bleeding. blood inside the body (especially into joints and muscles).

Xyntha Vial is a man-made form of clotting factor VIII. Xyntha Vial is used to control and prevent bleeding episodes in hemophilia A patients with low factor VIII levels.

Currently, in Vietnam, there are over 6,200 people with hemophilia and only about 50% of them are diagnosed and treated promptly. If this condition persists, it will progress to dangerous diseases. So what is hemophilia and is it possible for the disease to be hereditary?